Oncology PracticeUterine cancer low in myomectomy with power morcellationFebruary 19, 2015Gynecologic Cancer
Oncology PracticeNew 9-valent HPV vaccine shown to be as effective as quadrivalent vaccineFebruary 18, 2015Gynecologic CancerPreventive CarePediatrics
The Journal of Community and Supportive OncologyWomen with self-reported lower-limb lymphedema after treatment for gynecological cancers: are they more likely to self-report psychosocial symptoms and less likely to use services?February 18, 2015Gynecologic CancerPatient & Survivor Care
Oncology PracticeBevacizumab-enhanced chemo ‘new standard’ in metastatic cervical cancerFebruary 17, 2015Gynecologic Cancer
Oncology PracticeShort-term hormone replacement therapy upped ovarian cancer riskFebruary 12, 2015Gynecologic Cancer
Oncology PracticeAggressive surgery doesn’t necessarily improve survival from advanced ovarian cancerFebruary 12, 2015Gynecologic Cancer
Oncology PracticeTreating VTE in patients with gynecologic malignanciesFebruary 6, 2015Gynecologic Cancer
Oncology PracticePanel: HPV test can be primary screen for cervical cancerFebruary 2, 2015Gynecologic Cancer
Oncology PracticeEverolimus/letrozole combo provides clinical benefit in recurrent endometrial cancerJanuary 26, 2015Gynecologic Cancer
Oncology PracticeMetabolic syndrome linked to increased risk for most endometrial cancer subtypesJanuary 13, 2015Gynecologic CancerRare Diseases
Oncology PracticePatients cured of gestational trophoblastic tumors rarely develop subsequent malignancyJanuary 7, 2015Gynecologic CancerRare Diseases
Oncology PracticeBisphosphonates may protect against endometrial cancerDecember 22, 2014Gynecologic CancerPreventive CareRare Diseases
Oncology PracticeFDA approves PARP-inhibitor for ovarian cancerDecember 19, 2014Gynecologic CancerRare Diseases
The Journal of Community and Supportive OncologyPredictors of resolution in navigated patients with abnormal cancer screening testsDecember 17, 2014Breast CancerGynecologic CancerPatient & Survivor Care
